InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0001870278-25-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-05 2025-11-03 INSM Smith Michael Alexander CLO M - OptEx $23.75 +27.1K 82.0K +49% +$644.3K
DM 2025-11-05 2025-11-03 INSM Smith Michael Alexander CLO S - Sale+OE $183.78 -27.1K 64.8K -30% -$4.99M
D 2025-11-05 2025-11-03 INSM Smith Michael Alexander CLO M - OptEx $0.00 -27.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-03 M A 27,130 $23.75 82,032 D — —
2 Common Common Stock 2025-11-03 S D 1,342 $181.01 80,690 D — — (F2) This is the weighted average sales price representing 1,342 shares sold at prices ranging from $180.29 to $181.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
3 Common Common Stock 2025-11-03 S D 7,619 $181.88 73,071 D — — (F3) This is the weighted average sales price representing 7,619 shares sold at prices ranging from $181.30 to $182.29 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
4 Common Common Stock 2025-11-03 S D 4,286 $182.60 68,785 D — — (F4) This is the weighted average sales price representing 4,286 shares sold at prices ranging from $182.30 to $183.03 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
5 Common Common Stock 2025-11-03 S D 1,400 $187.97 54,902 D — — (F9) This is the weighted average sales price representing 1,400 shares sold at prices ranging from $187.88 to $188.13 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
6 Common Common Stock 2025-11-03 S D 3,243 $184.91 61,510 D — — (F6) This is the weighted average sales price representing 3,243 shares sold at prices ranging from $184.50 to $185.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
7 Common Common Stock 2025-11-03 S D 3,636 $185.93 57,874 D — — (F7) This is the weighted average sales price representing 3,636 shares sold at prices ranging from $185.51 to $186.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
8 Common Common Stock 2025-11-03 S D 1,572 $187.15 56,302 D — — (F8) This is the weighted average sales price representing 1,572 shares sold at prices ranging from $186.61 to $187.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
9 Common Common Stock 2025-11-03 S D 4,032 $183.92 64,753 D — — (F5) This is the weighted average sales price representing 4,032 shares sold at prices ranging from $183.49 to $184.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
10 Derivative Stock Option (right to buy) 2025-11-03 M D 27,130 $0.00 0 D $23.75 · — to 2030-01-03 27,130 Common Stock (F10) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.